RAINBOW PCLA MONO 27G60-100mm

Key Uses of Rainbow PCLA Mono 27G60-100mm

• Primary application in facial and neck regions requiring volume enhancement and gentle lifting
• Treatment of mild to moderate wrinkles and fine lines, particularly around the mouth and forehead
• Enhancement of skin elasticity and texture through collagen stimulation
• Reshaping of facial contours, especially in areas with high mobility
• Restoration of skin hydration and overall tissue health

Manufacturing Information for Rainbow PCLA Mono 27G60-100mm

Rainbow PCLA Mono 27G60-100mm is manufactured by Oreon Life Science, a leading South Korean medical device company specializing in advanced aesthetic solutions. The company is recognized for its expertise in developing premium threading technologies, including PDO and PLLA products, with a focus on innovation and safety in aesthetic medicine.

Expected Benefits and Results of the Treatment

• Extended bio-absorption period up to 18 months, surpassing traditional threading options

• Sustained stimulation of collagen and elastin production for continued rejuvenation

• Excellent tensile strength combined with medium hardness for natural-looking results

• Minimal risk of adverse reactions due to high biocompatibility

• Long-lasting rejuvenation effects that can extend beyond 2 years

• Alternative to surgical procedures with reduced downtime

Rainbow PCLA Mono 27G60-100mm Key Ingredients and Device Features

• Primary material: Poly L-Lactide-co-ε-Caprolactone (PCLA)
• Needle specifications: 27G gauge
• Thread length: 100mm
• Thread USP: 5-0mm
• Needle length: 60mm
• Package contents: 20 PCLA mono threads per box
• Unique composition: Combines benefits of both PLLA and PCL materials
• Biodegradable properties: Complete absorption within 18 months

Included Items or Accessories

• Set of 20 sterile PCLA mono threads
• Detailed product documentation and instructions
• Sterile packaging for each individual thread
• Complete treatment guides and protocols

Administration Method for Rainbow PCLA Mono 27G60-100mm

The procedure should be performed only by qualified medical professionals following these steps:

1. Conduct thorough patient consultation and medical history review
2. Clean and disinfect the treatment area thoroughly
3. Apply an appropriate local anaesthetic
4. Create marking guidelines for thread insertion
5. Insert threads using the 27G needle into the appropriate tissue depth
6. Secure thread placement and remove the insertion needle
7. Assess immediate results and monitor for any adverse reactions
8. Provide detailed aftercare instructions

Guidelines for Proper Aftercare

Patients should follow these post-treatment recommendations:

• Avoid alcohol consumption and blood-thinning medications for 24 hours

• Stay away from high-moisture environments like pools, saunas, and steam rooms

• Discontinue vitamins C and E for 10 days post-treatment

• Apply sunscreen regularly and avoid direct sun exposure

• Sleep on your back to prevent thread displacement

• Limit physical activity for at least 24 hours

• Avoid applying makeup for two days

• Follow the prescribed skincare routine as recommended by the practitioner

Duration of Rainbow PCLA Mono 27G60-100mm Effects

The treatment delivers both immediate and long-term results. The PCLA threads remain active in the tissue for approximately 18 months before complete biodegradation. Patients typically experience enhancement effects lasting up to 2 years, thanks to the sustained collagen and elastin production stimulated by the treatment. The extended absorption period of these fourth-generation threads contributes to their longer-lasting rejuvenating benefits compared to traditional options.

Potential Risks and Side Effects

Common side effects:

• Temporary discomfort and tenderness

• Localized swelling and redness

• Minor bruising at insertion sites

• Mild pain during initial recovery

Rare complications:

• Infection at treatment sites

• Thread displacement or protrusion

• Facial asymmetry

• Allergic responses

• Thread breakage

Rainbow PCLA Mono 27G60-100mm Treatment Contraindications

Treatment is not suitable for:

• Individuals under 18 years of age

• Pregnant or nursing mothers

• Patients with active autoimmune conditions

• Those with ongoing skin infections

• Individuals taking blood-thinning medications

• People with known polymer allergies

• Patients recovering from recent facial procedures

• Those with untreated medical conditions